BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Subbu Nambi does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 TWSTTwist Bioscience Corp | Buy | $50.00 | May 2025 | +72.3% | Hit |
 CYRXCryoport Inc | Buy | $10.00 | Apr 2025 | +45.5% | Hit |
 NEOGNeogen Corporation | Buy | $13.00 | Apr 2025 | +59.3% | Miss |
 VCYTVeracyte Inc | Buy | $37.00 | Apr 2025 | −9.0% | Hit |
| VCYTVeracyte Inc | Buy | $45.00 | Feb 2025 | −8.1% | Hit |
| NEOGNeogen Corporation | Buy | $15.00 | Dec 2024 | −54.5% | Miss |
 NAUTNautilus Biotechnology Inc | Buy | $6.00 | Jun 2024 | −63.8% | Miss |
 SOPHSophia Genetics SA | Buy | $6.00 | Jun 2024 | −26.0% | Miss |
 CSTLCastle Biosciences Inc | Buy | $25.00 | Dec 2023 | +37.1% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.